JOURNAL OF PRACTICAL HEPATOLOGY ›› 2010, Vol. 13 ›› Issue (4): 265-271.doi: 10.3969/j.issn.1672-5069.2010.04.009

Previous Articles     Next Articles

PvuⅡ genotype polymorphism of estrogen receptor alpha and early response to interferon-alpha treatment in patients with chronic hepatitis B

ZHANG Tingting,ZHANG Zhenhua,YE Jun,et al.   

  1. Department of Infectious Disease,First Affiliated Hospital,Anhui Medical University,Hefei 23002,China
  • Received:2009-11-12 Online:2010-08-10 Published:2016-04-18

Abstract: Objective To investigate the relationship between estrogen receptor α gene polymorphisms and therapeutic response to interferon-alpha in patients with chronic hepatitis B. Methods PvuII polymorphisms of estrogen receptor α(ESR1)gene were analyzed in 100 naive patients with chronic hepatitis B receiving interferon-alpha treatment by polymerase chain reaction-restriction fragment length polymorphism technique. Results Among PP,Pp and pp genotype group,the early virological response were markedly higher in PP genotype groups (70.8%) than 40.0% in Pp and 37.2% in pp genotype group(P<0.05),while neither the combined response nor HBeAg disappearance or seroconversion among PP,Pp and pp genotype groups had no significant difference(P>0.05). Conclusion PvuII genotype polymorphism of ESR1 is associated with early virological response to IFN-α in patients with CHB and the detection of PvuII genotype polymorphism might be helpful for predicting early response to IFN-α treatment.

Key words: Hepatitis B, Estrogen receptor, Polymorphism, Interferon-alpha, Early response